Deals Of The Week: Actelion/Trophos, Merck/Hawaii Biotech, Cypress/Ramius
Executive Summary
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.
You may also be interested in...
Vaccine Upstart Inviragen Aims to Capture Dengue Market
Six-year-old Inviragen may be the biotech of the future.
Vaccine Upstart Inviragen Aims to Capture Dengue Market
Six-year-old Inviragen may be the biotech of the future.
First Deal Of Scangos Era Brings Phase II ALS Candidate To Biogen Idec
Big biotech pays $80 million to Knopp Biosciences for worldwide license to dexpramiprexole.